Clinical Trials Browser

Phase 2 × Denosumab × Dermatologic × Clear all

NCT03620019 2024-08-12

Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma

Phase 2 Completed

25 enrolled 16 charts

Melanoma